鹿瓜多肽治疗强直性脊柱炎临床观察

目的 采用鹿瓜多肽注射液(CCPI)治疗强直性脊柱炎(AS)并进行为期2 周的临床观察,以评价其对AS 病情的改善作用和安全性.方法 住院治疗的AS 患者96 例随机分为实验组和对照组各48 例,对照组采用塞来昔布、柳氮磺吡啶及甲氨蝶呤治疗,实验组则在此基础上给予CCPI治疗,疗程共2 周,观察巴斯脊柱炎活动指数(BASDAI)、巴斯脊柱炎功能指数(BASFI)、血沉(ESR)和C 反应蛋白(CRP)等指标的变化及不良反应.结果 两组患者治疗2 周与入组时比较,BASDAI和BASFI 评分明显改善,炎性指标ESR 和CRP 显著下降,差异均有统计学意义(P ＜0.05);经治疗2周两组间比较,BASDAI、BASFI、ESR 和CRP 实验组较对照组均有显著改善,差异有统计学意义(P ＜0.05).结论 CCPI 用于治疗AS 有病情改善作用,且不良反应轻微,可作为AS 的辅助治疗药物.     

肌肉能量技术治疗强直性脊柱炎活动期功能障碍疗效观察

目的:应用肌肉能量技术(MET)治疗强直性脊柱炎(AS),观察MET对AS活动期的疼痛、关节活动度、肌力、炎症指标的改善情况,寻求针对AS患者功能障碍的可行的物理治疗方法。方法:将AS活动期患者24例按照随机数字表分为实验组10例和对照组14例,2组均采用常规药物(塞来昔布)治疗,实验组同时接受MET治疗。针对AS不同的功能障碍点,以疼痛VAS评分为依据,分别运用MET技术中的多种治疗方法进行综合治疗,共治疗3个月。比较治疗前后2组的疼痛(VAS)、关节活动度(ROM)、肌力(MMT)、强直性脊柱炎Schober试验、Bath强直性脊柱炎病情活动性指数(BASDAI)、Bath强直性脊柱炎功能性指数(BASFI)及红细胞沉降率(ESR)、C反应蛋白(CRP)水平。结果 :(1)与治疗前比较,实验组疼痛VAS、BASFI、BASDAI、ESR、CRP明显降低(P0.05),肌力、颈椎ROM、胸椎ROM、腰椎ROM、Schober评分明显升高(P0.05);对照组疼痛VAS、ESR明显降低(P0.05)。(2)与对照组比较,实验组治疗后疼痛VAS、BASFI、BASDAI明显降低(P0.05),肌力、腰椎ROM、Schober评分明显升高(P0.05)。结论 :肌肉能量技术可应用于活动期的强直性脊柱炎患者,对疼痛、腰椎关节活动度、肌力、强直性脊柱炎功能指标的改善具有明显的疗效。     

来氟米特联合甲氨蝶呤治疗强直性脊柱炎的临床疗效观察

目的:评估来氟米特联合甲氨蝶呤治疗强直性脊柱炎的疗效和不良反应.方法:将90例强直性脊柱炎患者分为治疗组来氟米特联合甲氨蝶呤、甲氨蝶呤组和柳氮磺胺吡啶组.分别于治疗前、治疗后3、6、12及18个月,监测3组患者的腰痛晨僵时间、疼痛关节数、ESR、CRP水平,Schober试验、扩胸度、指地距等指标.结果:治疗后3、6、12、18个月3组各项指标与治疗前比,腰痛晨僵时间、疼痛关节数、ESR、CRP水平、Schober试验、扩胸度、指地距均明显改善(P<0.05);治疗组与甲氡蝶呤组和柳氮磺胺吡啶组比较,腰痛晨僵时间、ESR、CRP改善明显(P<0.05).治疗组不良反应发生率明显低于甲氨蝶呤组、柳氮磺胺吡啶组(P<0.05).结论:来氟米特联合甲氨蝶呤治疗强直性脊柱炎疗效明显,不良反应少.     

短期应用仙灵骨葆联合柳氮磺胺吡啶维持治疗强直性脊柱炎的疗效

目的探讨短期应用仙灵骨葆联合柳氮磺胺吡啶(SSZ)治疗强直性脊柱炎(AS)的临床疗效。方法 60例AS患者分成实验组和对照组各30例。实验组口服仙灵骨葆胶囊及SSZ连续12个周,对照组口服SSZ治疗12个周。于第1、3、6、12周评价患者的强直性脊柱炎病情活动指数(BASDAI)、巴氏强直性脊柱炎功能指数(BASFI)、BASDAI和BASFI改善百分比、血沉(ESR)、C反应蛋白(CRP)、AS20%、AS50%。结果第1个周后,2组BASDAI评分相比有显著差异。治疗第3个周后,2组BASFI评分相比有显著差异。治疗第6、12个周后,2组BASDAI评分及BASFI评分相比均有显著差异。实验组ESR、CRP在治疗1周后即出现持续下降,而对照组3个周后呈持续下降。2组治疗过程中均无严重不良反应。结论应用仙灵骨葆胶囊联合SSZ治疗AS患者的效果优于单用SSZ。     

鹿瓜多肽对强直性脊柱炎病情的改善作用

目的采用鹿瓜多肽注射液（cervus and cucumis polypeptid einjection,CCPI）治疗强直性脊柱炎（ankylosing spondylitis,AS）并进行为期3周的临床观察,以评价其对AS病情的改善作用和安全性。方法住院治疗的AS患者108例随机分为实验组和对照组各54例,对照组采用非甾体类抗炎药（NSAIDs）和来氟米特（leflunomide,LEF）治疗,实验组则在此基础上给予CCPI治疗,疗程共3周,观察腰背痛、腰背晨僵时间、巴斯脊柱炎活动指数（BASDAI）、巴斯脊柱炎功能指数（BASFI）、ESR和CRP等指标的变化及不良反应。结果两组患者治疗3周与入组时比较,腰背痛发生率明显下降,腰背部晨僵时间显著减短,BASDAI和BASFI评分明显改善,炎性指标ESR和CRP显著下降,差异均有统计学意义（P〈0．05）;经治疗3周两组间比较,腰背痛发生率、腰背部晨僵时间、BASDAI、BASFI、ESR和CRP,实验组较对照组均有显著改善。差异有统计学意义（P〈0．05）。不良反应主要以胃肠道反应为主,有个别皮疹发生,两组间差异无统计学意义。结论CCPI用于治疗AS有病情改善作用,且不良反应较轻,可作为AS的辅助治疗药物。     

中药熏蒸配合功能锻炼在早期强直性脊柱炎康复治疗中的应用

目的探讨中药熏蒸配合功能锻炼在早期强直性脊柱炎患者康复护理中的应用效果。方法40例早期强直性脊柱炎患者随机分为对照组与治疗组,各20例。对照组采用口服药物治疗,配合护理护理措施;治疗组在对照组基础上增加中药熏蒸联合功能锻炼。比较2组患者的Bath强直性脊柱炎病情活动性指数(BASDAI)、Bath强直性脊柱炎功能指数(BASFI)、晨僵时间、红细胞沉降率(ESR)、C反应蛋白(CRP)水平。结果治疗后,2组BASDAI和BASFI评分均较治疗前下降,晨僵时间均较治疗前缩短,且治疗组BASDAI评分、BASFI评分和晨僵时间改善优于对照组(P<0.01)。治疗后,2组ESR和CRP水平较治疗前下降,且治疗组ESR和CRP水平低于对照组(P<0.01)。结论在常规药物治疗的基础上,配合中药熏洗和功能锻炼可进一步改善早期强直性脊柱炎患者的炎性指标、肢体功能和日常生活质量。     

依那西普联合沙利度胺治疗强直性脊柱炎的临床研究

目的评价肿瘤坏死因子抑制剂依那西普联合沙利度胺治疗强直性脊柱炎（AS）的临床疗效和安全性。方法应用依那西普治疗52例AS患者,25mg／次,每周1次,疗程12周,同时加用沙利度胺50—100mg每晚一次,记录治疗前后患者的症状、体征、AS疾病活动指数（BASDAI）、AS的功能指数（BASFI）、红细胞沉降率（ESR）及C-反应蛋白（CRP）等实验室指标及不良反应。结果依那西普治疗后患者的脊柱痛与夜间痛程度、晨僵时间均改善,指地距、BASDAI、BASFI均下降,与治疗前比较均有统计学差异（P〈0．05）。最常见的不良反应主要是注射部位反应和上呼吸道感染。结论依那西普联合沙利度胺对AS有显著的临床疗效,无严重不良反应。     

柳氮磺吡啶联合来氟米特治疗强直性脊柱炎的临床疗效观察

目的:评估柳氮磺吡啶(sulfasalazine,SSZ)联合来氟米特(leflunomide,LEF)治疗强直性脊柱炎的疗效和不良反应。方法:将72例强直性脊柱炎患者随机分为治疗组SSZ+LEF,对照组SSZ+甲氨蝶呤Methotrexate(MTX),分别于治疗前和治疗后6及12个月监测两组患者的腰痛晨僵时间、疼痛关节数、Schober试验、扩胸度、指地距、BathAS活动指数(DASDAI)、BathAS功能指数(DASFI)、ESR、CRP水平等指标。结果:治疗12个月,SSZ+LEF组有效率为94.44%,SSZ+MTX组有效率为83.33%,两组总体疗效差异无统计学意义(P>0.05);治疗后6、12个月两组各项指标与治疗前比腰痛晨僵时间、疼痛关节数、ESR、CRP水平、Schober试验、扩胸度、指地距、DASDAI、DASFI均明显改善(P<0.05),治疗组与对照组比较腰痛晨僵时间、ESR、CRP、DASDAI改善明显(P<0.05),治疗组不良反应发生率明显低于对照组(P<0.05)。结论:SSZ+LEF治疗强直性脊柱炎疗效显著,不良反应少。     

益肾壮脊汤治疗强直性脊柱炎肾虚督寒证疗效观察

目的:观察益肾壮脊汤对强直性脊柱炎肾虚督寒证临床疗效的干预情况。方法:将72例符合纳入标准的强直性脊柱炎患者随机分为治疗组和对照组,每组36例。对照组口服柳氮磺吡啶和塞来昔布,4周为1个疗程。治疗组在对照组的基础上加服益肾壮脊汤治疗,1剂/d,4周为1个疗程;两组均治疗4个疗程。对比治疗后两组患者治疗前后中医证候积分、BathAS疾病活动指数(BASDAI)、BathAS功能指数(BASFI)、指地距、胸廓活动度、脊柱活动度及C反应蛋白(CRP)、血沉(ESR)水平。结果:治疗后两组中医症状积分均较治疗前下降(P0.05),治疗组中医症状积分下降幅度大于对照组(P0.05);两组BathAS疾病活动指数(BASDAI)、BathAS功能指数(BASFI)均较治疗前降低(P0.05),且治疗组降低幅度更大(P0.05);两组指地距、胸廓活动度、脊柱活动度指标较治疗前明显改善(P0.05),治疗组改善程度优于对照组差异有统计学显著(P0.05);两组C反应蛋白(CRP)、血沉(ESR)水平均较治疗前降低(P0.05),降低幅度治疗组大于对照组(P0.05);结论:使用益肾壮脊汤治疗强直性脊柱炎,可有效改善患者病情,较于单用西药口服,治疗效果更优,值得进一步临床推广。     

强直性脊柱炎综合康复治疗的疗效观察

目的观察综合康复治疗对强直性脊柱炎（AS）的疗效。 方法共选取64例AS患者,将其随机分为治疗组及对照组。2组均给予常规药物（如塞来昔布、柳氮磺吡啶等）治疗,治疗组在此基础上辅以综合康复治疗,包括行为干预、康复体操训练、物理因子及心理治疗等。于治疗前及治疗6个月后分别采用疼痛VAS评分、AS疾病活动指数(BASDAI)、AS躯体功能指数(BASFI)等对2组患者进行疗效评定,并同时对2组患者血沉（ESR）及C-反应蛋白（CRP）水平进行检测。 结果2组患者治疗前,其临床症状评分（包括疼痛VAS评分、BASDAI评分及BASFI评分）及实验室检查结果（包括ESR及CRP水平）组间差异均无统计学意义（P&rt;0.05）;经6个月相应治疗后,发现2组患者上述各项指标均较治疗前明显改善（P<0.05）;且以治疗组临床症状评分的改善幅度较显著,与对照组间差异具有统计学意义 (P<0.05) ;治疗后2组患者ESR及CRP水平组间差异仍无统计学意义（P&rt;0.05）。 结论综合康复治疗能进一步促进AS患者病情缓解,防止脊柱关节畸形,对提高患者生活质量具有重要意义。     

Effects of Multidisciplinary Team-Based Nurse-led Transitional Care on Clinical Outcomes and Quality of Life in Patients With Ankylosing Spondylitis

PurposeThe purpose of this study is to investigate the impact of transitional care by a nurse-led multidisciplinary team (MDT) on clinical outcomes and quality of life of patients with ankylosing spondylitis.MethodsA randomized control study design was used. Subjects were allocated randomly to an experimental group and a control group. The experimental group received intensive transitional care by a nurse-led MDT, whereas the control group received routine nursing care. Disease activity, spinal mobility, comprehensive function, health service utilization, and quality of life were assessed at the baseline and at six months with the Bath Ankylosing Spondylitis Metrology Index, the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI), a health service utilization questionnaire and version 2 of the Short Form-36 health survey.ResultsCompared with the baseline, the BASDAI, BASFI, emergency visits, hospitalizations, hospitalization days, and bodily pain, vitality, mental health, total score, and average score of version 2 of the Short Form-36 health survey were improved in the experimental group (p < .05), whereas only bodily pain, vitality, and role-emotional were improved in the control group (p < .05). At six months, the experimental group exhibited significantly more improvement on the BASDAI, BASFI, hospitalizations, all domains except Role-physical as well as total score and average score (p < .05) compared with the control group.ConclusionA MDT-based nurse-led transitional care improves clinical outcomes and quality of life of patients with ankylosing spondylitis. Future research should be carried out on modes of follow-up and family support.     

One-year follow-up of two exercise interventions for the management of patients with ankylosing spondylitis: a randomized controlled trial

OBJECTIVE: To assess the long-term effects on functional and mobility outcomes of two exercise interventions for the management of patients with ankylosing spondylitis. DESIGN: In an extended 12-mo follow-up of a randomized controlled trial, 40 patients who were diagnosed with ankylosing spondylitis according to the modified criteria of New York, allocated to control or experimental groups using a random numbers table, and who performed their respective exercise program at least three times per month, were included in this long-term study. The control group was treated during 15 sessions with a conventional exercise regimen in ankylosing spondylitis, whereas the experimental group received 15 sessions of exercises based on the treatment of the shortened muscle chains following the guidelines described by the Global Posture Reeducation method. These patients were followed up and assessed again 1 yr after entering the study, re-applying the same validated indexes: BASMI (Bath Ankylosing Spondylitis Metrology Index [tragus to wall distance, modified Schober test, cervical rotation, lumbar side flexion, and intermalleolar distance]), BASDAI (Bath Ankylosing Spondylitis Disease Activity Index), and BASFI (Bath Ankylosing Spondylitis Functional Index). RESULTS: The intragroup comparison between follow-up and post-intervention data showed that both groups decrease their clinical and functional measures during the follow-up period. This decrease was only significant for lumbar side flexion and intermalleolar distance measurements, being more significant in the control group (P = 0.001 and P = 0.002, respectively). Intragroup differences between follow-up and pre-intervention assessments revealed that improvements in all mobility measures of the BASMI index and in the BASFI index were partially maintained at the 12-mo follow-up in the experimental group but not in the control group. The intergroup comparison (unpaired t test analysis) between changes on each outcome during the long-term follow-up (post-follow-up; and pre-follow-up) showed no significant differences in the decrease between post-intervention and follow-up data between the study groups. On the other hand, the intergroup comparison between pre-intervention and follow-up data revealed significant differences in almost all mobility measures of the BASMI index (except for cervical rotation) and in the BASFI index, in favor of the experimental group. CONCLUSIONS: An exercise regimen based on the Global Posture Reeducation method and focusing on specific strengthening and flexibility exercises of the shortened muscle chains offers promising short- and long-term results in the management of patients who have ankylosing spondylitis.     

The relationship of clinical and laboratory measurements to two different radiological scoring methods in ankylosing spondylitis

Two different methods for scoring the severity of radiological changes in 19 patients with ankylosing spondylitis, using plain X-rays of the lumbar spine and sacroiliac (SI) joints, were assessed in relation to clinical and laboratory measurements. Bath Ankylosing Spondylitis Radiology Index (BASRI) and Stoke Ankylosing Spondylitis Spine Score (SASSS) were used to evaluate radiologic changes. Disease activity was assessed using Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). There was no correlation between duration of morning stiffness, night pain, laboratory variables (ESR, CRP, hemoglobin, platelets) and any of the radiological scores. No significant correlation was found between BASDAI and both of the radiological scores. BASRI and SASSS correlated significantly with occiput-to-wall distance, Schober test, and finger-to-fibula distance. There was no significant correlation of radiologic scores with finger-to-floor distance and chest expansion. Right and left SI joint scores correlated significantly with BASRI and SASSS. The good correlation between spinal indexes and lack of correlation between clinical indicators of disease activity supports the notion that these two radiological scoring methods are measures of disease severity or deformity rather than disease activity. Radiological scoring methods are fundamental for the diagnosis and progression in AS and BASRI may be a more practical and appropriate method.     

Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis

OBJECTIVES: The aims of this study were to investigate a possible relationship between the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and some acute phase reactant (APR) levels in patients with ankylosing spondylitis (AS). METHODS: Twenty outpatients who fulfilled the modified New York criteria for AS were included in the study. Laboratory activity was assessed by examining erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), haptoglobin (Hp), and beta2 microglobulin (beta2MG). Disease activity was assessed according to the BASDAI, which includes a 10-point visual analogue scale to measure pain, fatigue, morning stiffness, swelling, and areas of local tenderness. RESULTS: When APR values were analyzed for the BASDAI, a positive correlation between CRP and BASDAI was observed (r = 0.556, P < 0.05). There was no clear, statistically significant correlation between BASDAI and the other APRs (ESR, r = 0.328, P > 0.05; Hp, r = 0.035, P > 0.05; and beta2MG, r = -0.190, P > 0.05). CONCLUSIONS: Our data suggest that CRP is a better marker of disease activity than ESR, Hp, and beta2MG.     

甲氨蝶呤与柳氮磺吡啶治疗强直性脊柱炎的临床对比研究

目的：对甲氨蝶呤（methotrexate，MTX）和柳氯磺吡啶（sulfasalazine，SSZ）治疗强直性脊柱炎（ankylosing spondylitis，AS）的临床疗效进行长期对比观察，以评价两种药物治疗AS的有效性及安全性。方法：住院治疗的AS患者120例随机分为两组各60例，分别采用SSZ（SSZ组）、MTX（MTX组）治疗，两组患者年龄、性别、病程及病情相匹配，均选择一种非甾体类抗炎药作为基础疗法。随访3年的临床资料．包括症状体征、BathAS活动指数（BASDAI）、Bath AS功能指数（BASFI）、血沉和C反应蛋白等化验检查及不良反应。结果：两组患者随访第1、2、3年与入院时比较，腰骶痛明显减轻（P〈0．05）。晨僵时间显著缩短（P〈0．05），BASDAI和BASFI明显降低（P〈0．05），炎性指标血沉和C反应蛋白显著下降（P〈0．05）；而随访各阶段两组间差异均无统计学意义．不良反应以胃肠道反应和白细胞减少为主，胃肠道反应MTX组（5％）明显低于SSZ组（12％）（P〈0．05），白细胞减少两组间差异无统计学意义；随访所有病例无造血系统障碍发生。结论：MTX和SSZ治疗AS疗效相近。MTX不良反应较少，患者易耐受。采用MTX治疗AS有更多的优越性，其更长期的疗效及安全性有待进一步观察。     

Assessment of functional ability in younger and older patients with ankylosing spondylitis: performance of the bath ankylosing spondylitis functional index

OBJECTIVE: To determine whether the Bath Ankylosing Spondylitis Functional Index (BASFI) is applicable in older patients with ankylosing spondylitis and whether it shows major differences between younger and older patients with ankylosing spondylitis. DESIGN: BASFI total scores and every BASFI item of 202 patients with ankylosing spondylitis aged >or=60 yr (group A) and 267 patients with ankylosing spondylitis aged 相似文献   

Relationship between Vitamin D levels and pain and disease activity in patients with newly diagnosed axial spondyloarthritis

ObjectivesTo explore the relationship between Vitamin D levels and pain and disease activity in patients with newly diagnosed axial spondyloarthritis (axSpA).MethodsA convenience sample of 131 newly diagnosed axSpA patients and 60 healthy controls was recruited from July 2016 to December 2018. Serum 25-hydroxyvitamin D [25(OH)D] was measured to assess vitamin D levels. Disease activity was assessed by objective indicators [Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), the Bath Ankylosing Spondylitis Metrology Index (BASMI)], patient-reported questionnaires [the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Functional Index (BASFI)]. Pain intensity and interference were also assessed.ResultsVitamin D insufficiency [serum 25(OH) D levels<50 nmol/L]was found in 46 (35.1%) and 25 (43.3%) of the axSpA patients and the healthy controls, respectively. Female patients had higher risk (OR:4.928; 95% CI: 1.921–12.642) for vitamin D insufficiency than male patients. Vitamin D was positively correlated with CRP, ESR level, the BASFI, and the BASMI. Logistic regression showed that vitamin D levels were not associated with pain, or disease activity in the newly diagnosed axSpA patients. Gender was the only predictive variable for vitamin D levels.ConclusionsVitamin D insufficiency was prevalent in both newly diagnosed axSpA patients and healthy controls. There was no association between vitamin D and pain and disease activity in the newly diagnosed axSpA patients. Monitoring vitamin D levels is important and early intervention for vitamin D insufficiency is needed, especially in female patients.